867 related articles for article (PubMed ID: 30541274)
1. Self-Assembled Copper-Amino Acid Nanoparticles for in Situ Glutathione "AND" H
Ma B; Wang S; Liu F; Zhang S; Duan J; Li Z; Kong Y; Sang Y; Liu H; Bu W; Li L
J Am Chem Soc; 2019 Jan; 141(2):849-857. PubMed ID: 30541274
[TBL] [Abstract][Full Text] [Related]
2. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
[TBL] [Abstract][Full Text] [Related]
3. A ROS storm generating nanocomposite for enhanced chemodynamic therapy through H
Li Y; Wang J; Zhu T; Zhan Y; Tang X; Xi J; Zhu X; Zhang Y; Liu J
Nanoscale; 2024 May; 16(17):8479-8494. PubMed ID: 38590261
[TBL] [Abstract][Full Text] [Related]
4. Photothermal-reinforced and glutathione-triggered in Situ cascaded nanocatalytic therapy.
An P; Fan F; Gu D; Gao Z; Hossain AMS; Sun B
J Control Release; 2020 May; 321():734-743. PubMed ID: 32145265
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable Biomimic Copper/Manganese Silicate Nanospheres for Chemodynamic/Photodynamic Synergistic Therapy with Simultaneous Glutathione Depletion and Hypoxia Relief.
Liu C; Wang D; Zhang S; Cheng Y; Yang F; Xing Y; Xu T; Dong H; Zhang X
ACS Nano; 2019 Apr; 13(4):4267-4277. PubMed ID: 30901515
[TBL] [Abstract][Full Text] [Related]
6. pH-Activatable copper-axitinib coordinated multifunctional nanoparticles for synergistic chemo-chemodynamic therapy against aggressive cancers.
Ji M; Liu H; Wang H; Liang X; Wei M; Shi D; Gou J; Yin T; He H; Tang X; Zhang Y
Biomater Sci; 2023 Sep; 11(18):6267-6279. PubMed ID: 37545202
[TBL] [Abstract][Full Text] [Related]
7. H
Tang Z; Jiang S; Tang W; He Q; Wei H; Jin C; Wang S; Zhang H
Mol Pharm; 2023 Mar; 20(3):1717-1728. PubMed ID: 36809003
[TBL] [Abstract][Full Text] [Related]
8. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
9. Glutathione-triggered nanoplatform for chemodynamic/metal-ion therapy.
Liu M; Wu H; Wang S; Hu J; Sun B
J Mater Chem B; 2021 Nov; 9(45):9413-9422. PubMed ID: 34746940
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Copper Peroxide Nanodots for H
Lin LS; Huang T; Song J; Ou XY; Wang Z; Deng H; Tian R; Liu Y; Wang JF; Liu Y; Yu G; Zhou Z; Wang S; Niu G; Yang HH; Chen X
J Am Chem Soc; 2019 Jun; 141(25):9937-9945. PubMed ID: 31199131
[TBL] [Abstract][Full Text] [Related]
11. Nanotrains of DNA Copper Nanoclusters That Triggered a Cascade Fenton-Like Reaction and Glutathione Depletion to Doubly Enhance Chemodynamic Therapy.
Li Q; Wang F; Shi L; Tang Q; Li B; Wang X; Jin Y
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37280-37290. PubMed ID: 35968633
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib-Loaded Copper Peroxide Nanoparticles with Redox Balance Disrupting Capacity for Enhanced Chemodynamic Therapy against Tumor Cells.
Chen C; Tan Y; Xu T; Sun Y; Zhao S; Ouyang Y; Chen Y; He L; Liu X; Liu H
Langmuir; 2022 Oct; 38(40):12307-12315. PubMed ID: 36154182
[TBL] [Abstract][Full Text] [Related]
13. Eradication of solid tumors by chemodynamic theranostics with H
Wang N; Zeng Q; Zhang R; Xing D; Zhang T
Theranostics; 2021; 11(5):2334-2348. PubMed ID: 33500728
[TBL] [Abstract][Full Text] [Related]
14. H
Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
[TBL] [Abstract][Full Text] [Related]
15. Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy.
Tang W; Gao H; Ni D; Wang Q; Gu B; He X; Peng W
J Nanobiotechnology; 2019 May; 17(1):68. PubMed ID: 31109332
[TBL] [Abstract][Full Text] [Related]
16. One-Pot Synthesis-Biocompatible Copper-Tripeptide Complex as a Nanocatalytic Medicine to Enhance Chemodynamic Therapy.
Hu ZE; Li J; Wu ZN; Wei YJ; Liu YH; Wang N; Yu XQ
ACS Biomater Sci Eng; 2021 Apr; 7(4):1394-1402. PubMed ID: 33689270
[TBL] [Abstract][Full Text] [Related]
17. Redox Homeostasis Disruptors Based on Metal-Phenolic Network Nanoparticles for Chemo/Chemodynamic Synergistic Tumor Therapy through Activating Apoptosis and Cuproptosis.
Zhao F; Yu H; Liang L; Wang C; Shi D; Zhang X; Ying Y; Cai W; Li W; Li J; Zheng J; Qiao L; Che S; Yu J
Adv Healthc Mater; 2023 Nov; 12(29):e2301346. PubMed ID: 37369362
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Specific Expansion of Oxidative Stress by Glutathione Depletion and Use of a Fenton Nanoagent for Enhanced Chemodynamic Therapy.
Chen Q; Zhou J; Chen Z; Luo Q; Xu J; Song G
ACS Appl Mater Interfaces; 2019 Aug; 11(34):30551-30565. PubMed ID: 31397998
[TBL] [Abstract][Full Text] [Related]
19. Engineering H
Dirersa WB; Kan TC; Chang J; Getachew G; Ochirbat S; Kizhepat S; Wibrianto A; Rasal A; Chen HA; Ghule AV; Chou TH; Chang JY
ACS Appl Mater Interfaces; 2024 May; 16(19):24172-24190. PubMed ID: 38688027
[TBL] [Abstract][Full Text] [Related]
20. Chemodynamic therapy agents Cu(II) complexes of quinoline derivatives induced ER stress and mitochondria-mediated apoptosis in SK-OV-3 cells.
Shen WY; Jia CP; Mo AN; Liang H; Chen ZF
Eur J Med Chem; 2021 Nov; 223():113636. PubMed ID: 34175540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
